The CMCO strives to promote a culture of intellectual curiosity, focusing on career development and innovative approaches to science.
Center of Molecular and Cellular Oncology
The Center of Molecular and Cellular Oncology (CMCO) fosters and mentors physician-scientists as they advance their laboratory-based research programs to bridge fundamental cancer biology with clinical investigation for the translation of basic discoveries into better therapeutics, treatments or diagnosis. Physician-scientist faculty in the CMCO hold primary appointments in medical oncology or hematology at Yale Cancer Center (YCC), and participate in all divisional activities, interacting with other members of YCC. In addition, the CMCO members are part of one or more YCC Clinical Research Teams (CRTs) and YCC Research Programs relevant to their laboratory research and clinical interests, promoting a collaborative environment for the better understanding of cancer biology. As physician-scientists who spend most of their time engaged in laboratory research, interaction of CMCO members with full-time clinical colleagues promotes efficient communication of new laboratory insights into clinical trials, as well as early recognition of new clinical observations that warrant intensive laboratory investigation.
Contact Us
Markus Müschen, MD-PhD
Arthur H. and Isabel Bunker Professor of Hematology
Director, Center of Molecular and Cellular Oncology
Office Phone: 203-737-2792
Anand Vasudevan, PhD
Program Manager
Office Phone: 203-737-1268
Center of Molecular and Cellular Oncology
Yale Cancer Center
300 George Street, Suite 6400
New Haven, CT 06511
Yale Cancer Center Grand Rounds | January 5, 2021Markus Muschen, MD, PhD
Yale Cancer Center Grand Rounds | November 10, 2020Robbert Bona, MD and Jeffrey Ishizuka, MD, DPhil
Faculty
Arthur H. and Isabel Bunker Professor of Medicine (Hematology) and Professor of Immunobiology; Director, Center of Molecular and Cellular Oncology; Chief, Division of Basic Science, Yale Cancer Center
EducationPhD, Institute for Genetics Cologne, 2003; MD, Heinrich-Heine-Universität Düsseldorf, 1999Associate Professor of Internal Medicine (Medical Oncology & Hematology)
EducationMD, Harvard Medical School, 2013; DPhil, Oxford University, 2008; BA, Williams College, 2004Associate Professor of Internal Medicine (Medical Oncology & Hematology)
EducationMD, Harvard Medical School, 2007; PhD, Yale University, 2002Assistant Professor
EducationPhD, University of Cambridge , 2018; MSc, University of Edinburgh, 2014; MBChB, University of Edinburgh, 2010; BMedSci, University of Edinburgh, 2007Associate Professor of Internal Medicine (Medical Oncology and Hematology); Louis Goodman and Alfred Gilman Yale Scholar, Yale Cancer Center; Associate Director, Medical Oncology-Hematology Fellowship Program, Yale Cancer Center
EducationMD, Icahn School of Medicine at Mount Sinai, 2013; PhD, Courant Institute of Mathematical Sciences at New York University, 2012; AB, Princeton University, 2006Assistant Professor of Medicine (Hematology)
EducationPhD, University Paris Diderot, 2013; MS, University Pierre and Marie Curie, 2009; MS, Stockholm University, 2008; BS, University of Burgundy, 2007Assistant Professor of Internal Medicine (Medical Oncology/Hematology)
EducationMD, Yale School of Medicine, 2016; PhD, Yale School of Medicine, 2015; BS, Massachusetts Institute of Technology (MIT), 2009
- August 24, 2026Source: Survivornet (With Jeffrey Ishizuka, MD, DPhil)
‘A True Breakthrough’: Experts Say Personalized mRNA Vaccine Could Help Stop Melanoma From Returning and Become a New Standard of Care
- August 20, 2026Source: Everyday Health (With Jeffrey Ishizuka, MD, DPhil)
Personalized Cancer Vaccines Just Got One Step Closer to Reality
- August 19, 2026Source: WTNH-TV Online (with David Braun MD, PhD)
Who is most likely to be diagnosed with kidney cancer?
- August 12, 2026
Braun Wins KidneyCAN Catalyst Award
- July 28, 2026Source: Yale News
Genetics Influence How Cancer Arises—and How it Evolves
- June 16, 2026
Dr. Sarah Aitken Named Pew-Stewart Scholar